The Effect of Sodium Phosphocreatine on Perioperative Myocardial Injury in Patients Undergoing Peritoneal Dialysis Catheterization

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040905

Enrollment

Unknown

Registered

2020-12-15

Start date

2021-01-21

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal failure

Interventions

Group CP:Intravenous drip of creatine phosphate 30 mg / kg

Group C:Intravenous saline

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Methods: 60 patients, male and female, with ASA grade III-IV, aged 18-65 years, weighing 40-75kg, were selected for peritoneal dialysis catheterization.

Exclusion criteria

Exclusion criteria: 1. Arrhythmia, obvious heart failure and cardiogenic shock; 2. Allergic to creatine phosphate; 3. Local anesthetic allergy; 4. Patients with puncture site damage or infection.

Design outcomes

Primary

Measure	Time frame
blood pressure;Heart Rate;RPP;Perioperative cardiovascular adverse events;	—

Countries

China

Contacts

Public ContactYang Zhang

The First Affiliated Hospital of Nanchang University

mzzhangyang@126.com+86 13576080494

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026